DOI: http://dx.doi.org/10.18203/2349-2902.isj20221720

Clinico-pathological evaluation and co-morbidities in superior mesenteric artery thrombosis

Snehil Shukla, Urvashi Singh, Badri Prasad Patel, Vignesh .

Abstract


Background: Mesenteric artery thrombosis (MAT) is a condition involving occlusion of the arterial vascular supply of the intestinal system. It is a severe and potentially fatal illness typically of the superior mesenteric artery (SMA), which provides the primary arterial supply to the small intestine and ascending colon. The occlusion may occur due to underlying atherosclerotic disease or embolic occlusion from a distant source, as atrial fibrillation. The condition possesses a high mortality rate and prompt recognition and treatment are of utmost importance.

Methods: A retrospective, observational, single hospital base study done during the period from 2015 to 2020 in the department of surgery, Gandhi Medical College, Bhopal. Sample size was taken 50 patients.

Results: In our study, out of 50 patients, 34% patients were in the age group between 55-65 years, history of smoking was present in 44%, hypertension in 36%, past history of atrial fibrillation in 10%, signs of peritonitis were present in 62% patients. Out of 50 patients, 42% was operated while 58% were managed conservatively. Amongst operated patients, in 72% partial bowel resection was done while in 28% extensive bowel resection was done, 66% were discharged while 28% patients died, amongst 21 operated patients, 57% were discharged while 43% died.

Conclusions: In this study, SMA thrombosis is more common in patients with smoking, cardiac diseases (hypertension, atrial fibrillation, ischemic heart disease, CVA), dyslipidaemia. Early intervention as thrombolysis or bypass surgery is needed to prevent complications like extensive bowel ischemia.


Keywords


SMA, Thrombosis, Mesentery, Ischemia, Gangrene

Full Text:

PDF

References


Heys SD, Brittenden J, Crofts TJ. Acute mesenteric ischemia: the continuing difficulty in early diagnosis. Postgrad Med J. 1993;69(807):48-51.

Kurland B, Brandt LJ, Delany HM. Diagnostic tests for intestinal ischemia. Surg Clin North Am. 1992;72(1):85-105.

Galandiuk S, Fazio VW, Petras RE. Fluorescein endoscopy: a technique for noninvasive assessment of intestinal ischemia. Dis Colon Rectum. 1988;31(11):848-53.

Deehan DJ, Heys SD, Brittenden J, Eremin O. Mesenteric ischemia: prognostic factors and influence of delay upon outcome. J R Coll Surg Edinb. 1995;40(2):112-5.

Kurland B, Brandt LJ, Delany HM. Diagnostic tests for intestinal ischemia. Surg Clin North Am. 1992;72(1):85-105.

Evennett NJ, Petrov MS, Mittal A, Windsor JA. Systematic review and pooled estimates for the diagnostic accuracy of serological markers for intestinal ischemia. World J Surg. 2009;33(7):1374-83.

Degerli V, Ergin I, Duran FY, Ustuner MA, Duran O. Could mean platelet volume be a reliable indicator for acute mesenteric ischemia diagnosis? A case control study. Biomed Res Int. 2016;2016:9810280.

Matsumoto S, Sekine K, Funaoka H, Yamazaki M, Shimizu M, Hayashida K, et al. Diagnostic performance of plasma biomarkers in patients with acute intestinal ischemia. Br J Surg. 2014;101(3):232-8.

Cudnik MT, Darbha S, Jones J, Macedo J, Stockton SW, Hiestand BC. The diagnosis of acute mesenteric ischemia: a systematic review and meta-analysis. Acad Emerg Med. 2013;20(11):1087-100.

Delaney CP, O’Neill S, Manning F, Fitzpatrick JM, Gorey TF. Plasma concentrations of glutathione s-transferase isoenzyme are raised in patients with intestinal ischemia. Br J Surg. 1999;86(10):1349-53.

Keating L, Benger JR, Beetham R, Bateman S, Veysey S, Kendall J, et al. The prima study: presentation ischemia- modified albumin in the emergency department. Emerg Med J. 2006;23(10):764-8.

Polk JD, Rael LT, Craun ML, Mains CW, Davis-Merritt D, Bar-Or D. Clinical utility of the cobalt-albumin binding assay in the diagnosis of intestinal ischemia. J Trauma. 2008;64(1):42-5.

Block T, Nilsson TK, Bjorck M, Acosta S. Diagnostic accuracy of plasma biomarkers for intestinal ischemia. Scand J Clin Lab Invest. 2008;68(3):242-8.

Cosse C, Sabbagh C, Kamel S, Galmiche A, Regimbeau JM. Procalcitonin and intestinal ischemia: a review of the literature. World J Gastroenterol. 2014;20(47):17773-8.

Murray MJ, Gonze MD, Nowak LR, Cobb CF. Serum d(-)-lactate levels as an aid to diagnosing acute intestinal ischemia. Am J Surg. 1994;167(6):575-8.

Poeze M, Froon AH, Greve JW, Ramsay G. D-lactate as an early marker of intestinal ischemia after ruptured abdominal aortic aneurysm repair. Br J Surg. 1998;85(9):1221-4.

Kittaka H, Akimoto H, Takeshita H, Funaoka H, Hazui H, Okamoto M, et al. Usefulness of intestinal fatty acid- binding protein in predicting strangulated small bowel obstruction. PLoS One. 2014;9(6):99915.

Kulu R, Akyildiz H, Akcan A, Ozturk A, Sozuer E. Plasma citrulline measurement in the diagnosis of acute mesenteric ischemia. ANZ J Surg. 2017;87(9):57-60.

Salim SY, Young PY, Churchill TA, Khadaroo RG. Urine intestinal fatty acid-binding protein predicts acute mesenteric ischemia in patients. J Surg Res. 2017;209:258-65.

Ewaschuk JB, Naylor JM, Zello GA. D-lactate in human and ruminant metabolism. J Nutr. 2005;135(7):1619-25.

Marti R, Varela E, Segura RM, Alegre J, Surinach JM, Pascual C. Determination of d-lactate by enzymatic methods in biological fluids: study of interferences. Clin Chem. 1997;43:1010-5.

Sapin V, Nicolet L, Aublet-Cuvelier B, Sangline F, Roszyk L, Dastugue B, et al. Rapid decrease in plasma d-lactate as an early potential predictor of diminished 28-day mortality in critically ill septic shock patients. Clin Chem Lab Med. 2006;44(4):492-6.